Ausgabe 1/2016
30th Year Celebration Issue! Special Issue on Biological Causality: When Experimental Models and Human Genetics Conflict
Inhalt (11 Artikel)
Experimental Biology for the Identification of Causal Pathways in Atherosclerosis
Yanhong Guo, Minerva T. Garcia-Barrio, Laiyuan Wang, Y. Eugene Chen
Identifying new Risk Markers and Potential Targets: The Value of the Proteome
Anatol Kontush
Identifying new Risk Markers and Potential Targets for Coronary Artery Disease: The Value of the Lipidome and Metabolome
Reijo Laaksonen
Atherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications
Jeremy D. Kratz, Ashish Chaddha, Somnath Bhattacharjee, Sascha N. Goonewardena
Mendelian Randomization for the Identification of Causal Pathways in Atherosclerotic Vascular Disease
Henning Jansen, Wolfgang Lieb, Heribert Schunkert
Pharmacogenomics to Revive Drug Development in Cardiovascular Disease
Marie-Pierre Dubé, Simon de Denus, Jean-Claude Tardif
Mendelian Randomization Analyses for Selection of Therapeutic Targets for Cardiovascular Disease Prevention: a Note of Circumspection
Robert S. Rosenson, Wolfgang Koenig
Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis
Calvin Yeang, Bruno Cotter, Sotirios Tsimikas
Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
Florian Kronenberg
Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease
Evan A. Stein, Frederick Raal